In Vitro Biopredictive Methods: A Workshop Summary Report.
Bioequivalence
Biopredictive dissolution
CQAs
IVIVC
IVIVR
Modeling
PBBM
PBPK
Permeability
Precipitation
Solubility
Journal
Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
19
08
2020
revised:
14
09
2020
accepted:
14
09
2020
pubmed:
22
9
2020
medline:
22
6
2021
entrez:
21
9
2020
Statut:
ppublish
Résumé
This workshop report summarizes the proceedings of Day 1 of a three-day workshop on "Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls". Physiologically based biopharmaceutics models (PBBM) are tools which enable the drug product quality attributes to be linked to the in vivo performance. These tools rely on key quality inputs in order to provide reliable predictions. After introducing the objectives of the workshop and the expectations from the breakout sessions, Day 1 of the workshop focused on the best practices and challenges in measuring in vitro inputs needed for modeling, such as the drug solubility, the dissolution rate of the drug product, potential precipitation of the drug and drug permeability. This paper reports the podium presentations and summarizes breakout session discussions related to A) the best strategies for determining solubility, supersaturation and critical supersaturation; B) the best strategies for the development of biopredictive (clinically relevant) dissolution methods; C) the challenges associated with describing gastro-intestinal systems parameters such as mucus, liquid volume and motility; and D) the challenges with translating biopharmaceutical measures of drug permeability along the gastrointestinal tract to a meaningful model parameter.
Identifiants
pubmed: 32956678
pii: S0022-3549(20)30549-9
doi: 10.1016/j.xphs.2020.09.021
pii:
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
567-583Subventions
Organisme : FDA HHS
ID : U01 FD005946
Pays : United States
Informations de copyright
Copyright © 2020 American Pharmacists Association®. All rights reserved.